ALLUVI TIRZEPATIDE Pre-Filled Pen (40mg) – Dual Agonist Research Compound

The Alluvi Tirzepatide 40mg Pen is a precision-formulated investigational peptide device developed for laboratory and metabolic research applications. Manufactured by Alluvi Healthcare, this prefilled pen contains Tirzepatide, a potent dual GIP and GLP-1 receptor agonist actively studied in metabolic pathway and glycemic regulation models. Alluvi Tirzepatide 40mg Pen

Each pen delivers a total peptide content of 40mg in a stabilized liquid solution format designed for controlled and repeatable research administration. The convenient pen system removes the need for manual reconstitution while supporting accurate, unit-dial dose selection.

Key Features

• 40mg total Tirzepatide peptide content

• Dual GIP & GLP-1 receptor agonist investigational compound

• Targeted research for glycemic control, beta-cell function, and energy balance pathways

• Prefilled research pen with multi-dose precision delivery format

• No reconstitution required – pre-mixed, stabilized liquid formulation

• Precision dial-a-dose laboratory delivery system

• High-purity device manufactured by Alluvi Healthcare

How to Use

• Attach a sterile compatible needle before use

• Prime according to package instructions if required

• Select the desired dose for institutional research protocol

• Administer via subcutaneous route where applicable for controlled laboratory studies

• Store refrigerated between 2–8°C

How It Works

• Tirzepatide is investigated for dual GIP and GLP-1 receptor co-agonism to model synergistic metabolic and incretin signaling pathways.

• Research focuses on glucose-dependent insulin secretion, glucagon suppression, and lipid homeostasis mechanisms.

• The Alluvi prefilled pen format supports convenient laboratory administration without reconstitution variability.

• Precision dosing mechanics allow controlled, reliable, and repeatable investigational outcomes across structured trial protocols.

Recommended Research Pairings

• May complement broader metabolic investigation and lipid regulation protocols.

• Often researched alongside Alluvi Retatrutide or Alluvi NAD+ within comprehensive metabolic and cellular bioenergetics research frameworks.

• Can be included within advanced multi-variable laboratory peptide studies.